Top Banner
Günther K. Bonn Institute of Analytical Chemistry and Radiochemistry, Leopold-Franzens University of Innsbruck, Innrain 80-82, A-6020 Innsbruck, Austria Austrian Drug Screening Institute – ADSI Innrain 66, A-6020 Innsbruck, Austria Office: Sensengasse, Vienna, Austria Grundlagen und Anwendung moderner Trennverfahren Teil 2 – Solid Phase Extraction - SPE
81

Grundlagen und Anwendung moderner Trennverfahren · Mono-phosphorylated peptide (m/z . 2252.25) identified as RIADPEHDHTGFLTE. p. YVATRW (SwissProt as database) MS/MS analysis of

Aug 22, 2020

Download

Documents

dariahiddleston
Welcome message from author
This document is posted to help you gain knowledge. Please leave a comment to let me know what you think about it! Share it to your friends and learn new things together.
Transcript
Page 1: Grundlagen und Anwendung moderner Trennverfahren · Mono-phosphorylated peptide (m/z . 2252.25) identified as RIADPEHDHTGFLTE. p. YVATRW (SwissProt as database) MS/MS analysis of

Günther K. BonnInstitute of Analytical Chemistry and Radiochemistry, Leopold-Franzens

University of Innsbruck, Innrain 80-82, A-6020 Innsbruck, Austria

Austrian Drug Screening Institute – ADSIInnrain 66, A-6020 Innsbruck, AustriaOffice: Sensengasse, Vienna, Austria

Grundlagen und Anwendung moderner Trennverfahren

Teil 2 – Solid Phase Extraction - SPE

Page 2: Grundlagen und Anwendung moderner Trennverfahren · Mono-phosphorylated peptide (m/z . 2252.25) identified as RIADPEHDHTGFLTE. p. YVATRW (SwissProt as database) MS/MS analysis of

Genome Transcription Proteome Metabolome

Transcription TranslationPost-translational Modification

DNA RNA Proteins Modified Proteins Biological Function

Environment

~30,000 Genes > 1,000,000 ProteinsPathways1500-2000Metabolites

Herausforderung Moderner TrennverfahrenGenomics – Proteomics - Metabolomics

2

Page 3: Grundlagen und Anwendung moderner Trennverfahren · Mono-phosphorylated peptide (m/z . 2252.25) identified as RIADPEHDHTGFLTE. p. YVATRW (SwissProt as database) MS/MS analysis of

Genomics

Proteomics

MetabolomicsStationary PhasesMaterial Science

Separation

InstrumentationMS, NMR, Spectroscopy

New Analytical ApproachesBionalysis

DiagnosticsBiomarker Discovery

Purification and Enrichment

Data InterpretationData Analysis

Therapy

Omics - Overview

Stationary PhasesMaterial Science

Separation

Page 4: Grundlagen und Anwendung moderner Trennverfahren · Mono-phosphorylated peptide (m/z . 2252.25) identified as RIADPEHDHTGFLTE. p. YVATRW (SwissProt as database) MS/MS analysis of

Omics - Overview

N Ca

Traditional techniques

(magnetic resonance,Ultrasound, CT…)

SAMPLEbiofluids

Genomic

Proteomic

MetabolomicA

naly

sis NMR, LC-MS,GC-MS, PCR,

Imaging, rt-PCR,ELISA, Chip-Array,…

Screening

DiagnosticsBiomarker Discovery

Therapy

Page 5: Grundlagen und Anwendung moderner Trennverfahren · Mono-phosphorylated peptide (m/z . 2252.25) identified as RIADPEHDHTGFLTE. p. YVATRW (SwissProt as database) MS/MS analysis of

Medicine

Biomarker screeninge.g. discovery of novel disease markers,targets and leads

biomarker

analytical toolsin medicine e.g. LC-MS, SPE

Phytochemistry

Screening of natural productse.g. discovery of novel active compounds,quality control

active compound

analytical toolsin phytopharmacy e.g. chromatography

Analytical Chemistry allows exploring inaccessible areas in Phytopharmacy and Medicine

Analytical Chemistry provides the fundamental strategies and technologies

of more or less all disciplines in natural sciences including phytopharmacy and medicine Analytical

Chemistryallows to see

the nature

Page 6: Grundlagen und Anwendung moderner Trennverfahren · Mono-phosphorylated peptide (m/z . 2252.25) identified as RIADPEHDHTGFLTE. p. YVATRW (SwissProt as database) MS/MS analysis of

Why Analytical Innovations?

High sample throughput

Improved detection limit

Needle in haystack

Speed

Sensitivity

Selectivity

„To see what one could not see before“

Page 7: Grundlagen und Anwendung moderner Trennverfahren · Mono-phosphorylated peptide (m/z . 2252.25) identified as RIADPEHDHTGFLTE. p. YVATRW (SwissProt as database) MS/MS analysis of

Fällung• Spezifische Fällung von

Phosphoproteinen und Phosphopeptiden

Extraktion

• Festphasenextraktion• Anreicherung von Proteinen

und Peptiden• Entsalzung

Chromato-graphie

• Affinität• Chromatographie• HPLC/UHPLC

Massen-spektrometrie

• SELDI• MELDI• Mf-MELDI

Moderne Trennverfahren

Überblick

7

Page 8: Grundlagen und Anwendung moderner Trennverfahren · Mono-phosphorylated peptide (m/z . 2252.25) identified as RIADPEHDHTGFLTE. p. YVATRW (SwissProt as database) MS/MS analysis of

Bioanalysis - Serum - Biomarker

8

Page 9: Grundlagen und Anwendung moderner Trennverfahren · Mono-phosphorylated peptide (m/z . 2252.25) identified as RIADPEHDHTGFLTE. p. YVATRW (SwissProt as database) MS/MS analysis of

Bioanalysis - Complexity of Human Serum

22 proteins are approx. 99% of the whole serum proteome

90% 10%

9

Page 10: Grundlagen und Anwendung moderner Trennverfahren · Mono-phosphorylated peptide (m/z . 2252.25) identified as RIADPEHDHTGFLTE. p. YVATRW (SwissProt as database) MS/MS analysis of

Anderson, N. L. (2002) Mol. Cell. Proteomics 1: 845-867

Protein abundance in human plasmaDynamic Range

Page 11: Grundlagen und Anwendung moderner Trennverfahren · Mono-phosphorylated peptide (m/z . 2252.25) identified as RIADPEHDHTGFLTE. p. YVATRW (SwissProt as database) MS/MS analysis of

Warum das Proteom untersuchen ?

Das Genom sagt, was potentiell in einer Zelle passieren könnte,

das Proteom sagt, was tatsächlich passiert.

11

Page 12: Grundlagen und Anwendung moderner Trennverfahren · Mono-phosphorylated peptide (m/z . 2252.25) identified as RIADPEHDHTGFLTE. p. YVATRW (SwissProt as database) MS/MS analysis of

12

Page 13: Grundlagen und Anwendung moderner Trennverfahren · Mono-phosphorylated peptide (m/z . 2252.25) identified as RIADPEHDHTGFLTE. p. YVATRW (SwissProt as database) MS/MS analysis of

Genomics/Proteomics

13

Page 14: Grundlagen und Anwendung moderner Trennverfahren · Mono-phosphorylated peptide (m/z . 2252.25) identified as RIADPEHDHTGFLTE. p. YVATRW (SwissProt as database) MS/MS analysis of

Festphasenextraktion - Prinzip

14

Page 15: Grundlagen und Anwendung moderner Trennverfahren · Mono-phosphorylated peptide (m/z . 2252.25) identified as RIADPEHDHTGFLTE. p. YVATRW (SwissProt as database) MS/MS analysis of

15

Festphasenextraktion - Prinzip

Page 16: Grundlagen und Anwendung moderner Trennverfahren · Mono-phosphorylated peptide (m/z . 2252.25) identified as RIADPEHDHTGFLTE. p. YVATRW (SwissProt as database) MS/MS analysis of
Page 17: Grundlagen und Anwendung moderner Trennverfahren · Mono-phosphorylated peptide (m/z . 2252.25) identified as RIADPEHDHTGFLTE. p. YVATRW (SwissProt as database) MS/MS analysis of
Page 18: Grundlagen und Anwendung moderner Trennverfahren · Mono-phosphorylated peptide (m/z . 2252.25) identified as RIADPEHDHTGFLTE. p. YVATRW (SwissProt as database) MS/MS analysis of

Nernst distribution coefficient

Konzentration des Analyten in der stationären Phase

Konzentration des Analyten in der mobilen Phase

Page 19: Grundlagen und Anwendung moderner Trennverfahren · Mono-phosphorylated peptide (m/z . 2252.25) identified as RIADPEHDHTGFLTE. p. YVATRW (SwissProt as database) MS/MS analysis of

Background of chromatographic methods

Page 20: Grundlagen und Anwendung moderner Trennverfahren · Mono-phosphorylated peptide (m/z . 2252.25) identified as RIADPEHDHTGFLTE. p. YVATRW (SwissProt as database) MS/MS analysis of

Important chromatography methods in proteomics

• Ion Exchange Chromatography(IEC)

• Size Exclusion Chromatography(SEC)

• Affinity Chromatography(AC)

• Reversed Phase Chromatography(RPC)

Page 21: Grundlagen und Anwendung moderner Trennverfahren · Mono-phosphorylated peptide (m/z . 2252.25) identified as RIADPEHDHTGFLTE. p. YVATRW (SwissProt as database) MS/MS analysis of

Ion Exchange Chromatography

• Separation is based on charge differences• Reversible interaction between oppositely charged solute and

chromatographic medium• Elution: increasing salt concentration or pH change• Solute molecules are eluted in a concentrated form• Ion exchange types:

– Anion Exchange Chromatography: negatively charged solute molecules compete with negatively charged mobile phase ions for the positively charged sites of the stationary phase

– Cation Exchange Chromatography: positively charged solute molecules compete with positively charged mobile phase ions for the negatively charged sites of the stationary phase.

Page 22: Grundlagen und Anwendung moderner Trennverfahren · Mono-phosphorylated peptide (m/z . 2252.25) identified as RIADPEHDHTGFLTE. p. YVATRW (SwissProt as database) MS/MS analysis of

Ion Exchange Chromatography

Carboxylic acidWeak cation

Sulfonic acidStrong cation

Tertiary amine

Secondary amine

Primary amineWeak anion

Quaternary AmineStrong anion

TypeFunctional groupType of Exchanger

Operating

N+ CH3

NH2

NH

N

SO3-

COO-

Page 23: Grundlagen und Anwendung moderner Trennverfahren · Mono-phosphorylated peptide (m/z . 2252.25) identified as RIADPEHDHTGFLTE. p. YVATRW (SwissProt as database) MS/MS analysis of

Size Exclusion Chromatography

• Solute molecules are separated by their size• Stationary phase has pores of well defined size• Retention is a function of solute penetration into the

pores that is proportional to the hydrodynamic volume of the solute

• No selective interaction with the stationary phase• Particularly useful for buffer exchange

Page 24: Grundlagen und Anwendung moderner Trennverfahren · Mono-phosphorylated peptide (m/z . 2252.25) identified as RIADPEHDHTGFLTE. p. YVATRW (SwissProt as database) MS/MS analysis of

Size Exclusion Chromatography

Page 25: Grundlagen und Anwendung moderner Trennverfahren · Mono-phosphorylated peptide (m/z . 2252.25) identified as RIADPEHDHTGFLTE. p. YVATRW (SwissProt as database) MS/MS analysis of

Affinity Chromatography

• Solute molecules are separated on the basis of specific reversible binding to an affinity ligand attached to the stationary phase.

• Utilizes very specific stationary phases such as antibodies, lectins, etc.

• Desorption is performed by adding a competitive ligand to the elution buffer system, or changing ionic strength, pH or polarity.

• The availability of the affinity ligand defines its applicability.

• Very specific for the solute molecule.

Page 26: Grundlagen und Anwendung moderner Trennverfahren · Mono-phosphorylated peptide (m/z . 2252.25) identified as RIADPEHDHTGFLTE. p. YVATRW (SwissProt as database) MS/MS analysis of

Affinity Chromatography

Most time a spacer is necessary to bind the affinity ligand to the stationary phase

Page 27: Grundlagen und Anwendung moderner Trennverfahren · Mono-phosphorylated peptide (m/z . 2252.25) identified as RIADPEHDHTGFLTE. p. YVATRW (SwissProt as database) MS/MS analysis of

Affinity ligands and applications

LIGAND • Avidin• Aprotinin• Biotin• Concanavalin A• Gelatin• Glutathione• Heparin• Iminoacetic acid• Lysine• Protein A• Phophorylethanolamine• Protein G• Protamine

APPLICATIONS• Biotin derivatives• Serine proteases• Avidin• Glycoproteins, Oligosaccharides• Fibornectine enzymes• Enzymes related to glutathione• Blood coagulation factors• Interferon, serum proteins• Plasminogen, polysaccharides• Human IgG• C-reactive protein• IgG immune complex• IgM

Curtesy of Dr. R. Bishoff

Page 28: Grundlagen und Anwendung moderner Trennverfahren · Mono-phosphorylated peptide (m/z . 2252.25) identified as RIADPEHDHTGFLTE. p. YVATRW (SwissProt as database) MS/MS analysis of

Reversed phase chromatography

• Solute separation is based on reversible hydrophobic interactions with a hydrophobic stationary phase

• Commonly used stationary phases are silica or polymer based with different chain length hydrocarbon ligands

• Due to strong binding, organic solvents are necessary for elution, sometimes with such additives as ion pairing agents.

• During RP-HPLC, proteins may get denatured or loose their biological activity

Page 29: Grundlagen und Anwendung moderner Trennverfahren · Mono-phosphorylated peptide (m/z . 2252.25) identified as RIADPEHDHTGFLTE. p. YVATRW (SwissProt as database) MS/MS analysis of
Page 30: Grundlagen und Anwendung moderner Trennverfahren · Mono-phosphorylated peptide (m/z . 2252.25) identified as RIADPEHDHTGFLTE. p. YVATRW (SwissProt as database) MS/MS analysis of
Page 31: Grundlagen und Anwendung moderner Trennverfahren · Mono-phosphorylated peptide (m/z . 2252.25) identified as RIADPEHDHTGFLTE. p. YVATRW (SwissProt as database) MS/MS analysis of
Page 32: Grundlagen und Anwendung moderner Trennverfahren · Mono-phosphorylated peptide (m/z . 2252.25) identified as RIADPEHDHTGFLTE. p. YVATRW (SwissProt as database) MS/MS analysis of
Page 33: Grundlagen und Anwendung moderner Trennverfahren · Mono-phosphorylated peptide (m/z . 2252.25) identified as RIADPEHDHTGFLTE. p. YVATRW (SwissProt as database) MS/MS analysis of
Page 34: Grundlagen und Anwendung moderner Trennverfahren · Mono-phosphorylated peptide (m/z . 2252.25) identified as RIADPEHDHTGFLTE. p. YVATRW (SwissProt as database) MS/MS analysis of
Page 35: Grundlagen und Anwendung moderner Trennverfahren · Mono-phosphorylated peptide (m/z . 2252.25) identified as RIADPEHDHTGFLTE. p. YVATRW (SwissProt as database) MS/MS analysis of
Page 36: Grundlagen und Anwendung moderner Trennverfahren · Mono-phosphorylated peptide (m/z . 2252.25) identified as RIADPEHDHTGFLTE. p. YVATRW (SwissProt as database) MS/MS analysis of

Je länger ein Stoff in der stationären Phase verbleibt, desto größer wird der

Kapazitätsfaktor und damit auch die Retentionszeit des Analyten. Der Kapazitätsfaktor

gibt an, um wieviel länger sich Moleküle an der stationären Phase im Vergleich zur

mobilen aufhalten. Mit Bruttoretentionszeit (tR) und Totzeit (t0) gilt:

Ein hoher Kapazitätsfaktor beschreibt ein hohes Retentionsverhalten!

Kapazitätsfaktor

Page 37: Grundlagen und Anwendung moderner Trennverfahren · Mono-phosphorylated peptide (m/z . 2252.25) identified as RIADPEHDHTGFLTE. p. YVATRW (SwissProt as database) MS/MS analysis of
Page 38: Grundlagen und Anwendung moderner Trennverfahren · Mono-phosphorylated peptide (m/z . 2252.25) identified as RIADPEHDHTGFLTE. p. YVATRW (SwissProt as database) MS/MS analysis of
Page 39: Grundlagen und Anwendung moderner Trennverfahren · Mono-phosphorylated peptide (m/z . 2252.25) identified as RIADPEHDHTGFLTE. p. YVATRW (SwissProt as database) MS/MS analysis of
Page 40: Grundlagen und Anwendung moderner Trennverfahren · Mono-phosphorylated peptide (m/z . 2252.25) identified as RIADPEHDHTGFLTE. p. YVATRW (SwissProt as database) MS/MS analysis of
Page 41: Grundlagen und Anwendung moderner Trennverfahren · Mono-phosphorylated peptide (m/z . 2252.25) identified as RIADPEHDHTGFLTE. p. YVATRW (SwissProt as database) MS/MS analysis of
Page 42: Grundlagen und Anwendung moderner Trennverfahren · Mono-phosphorylated peptide (m/z . 2252.25) identified as RIADPEHDHTGFLTE. p. YVATRW (SwissProt as database) MS/MS analysis of

Oasis Material (Waters)

Example

Page 43: Grundlagen und Anwendung moderner Trennverfahren · Mono-phosphorylated peptide (m/z . 2252.25) identified as RIADPEHDHTGFLTE. p. YVATRW (SwissProt as database) MS/MS analysis of

Oasis Material (Waters)Alternative to C18

Page 44: Grundlagen und Anwendung moderner Trennverfahren · Mono-phosphorylated peptide (m/z . 2252.25) identified as RIADPEHDHTGFLTE. p. YVATRW (SwissProt as database) MS/MS analysis of

IMACImmobilized metal-ion chromatography

Example

for specific binding of phosphopeptides!

Page 45: Grundlagen und Anwendung moderner Trennverfahren · Mono-phosphorylated peptide (m/z . 2252.25) identified as RIADPEHDHTGFLTE. p. YVATRW (SwissProt as database) MS/MS analysis of

Immobilized metal ion/Metal Chelate affinity chromatography is separation techniquethat is based on coordinate covalent binding between proteins and metal ions. Proteinshave a wide variety of amino acids composition which, in effect, generates a range ofdifferent affinities towards metal ions. However, not many naturally occurring proteinshave affinity for metal ions, so the technique is mainly used to purify recombinantproteins. For example proteins can be engineered to contain a poly-histidine tail(histidine can generally act as a ligand towards divalent metal cations). If the stationaryphase is immobilized with divalent metal cations, a mixture of proteins can beseparated based on their ability to interact with the metal ions. Those proteinscontaining a higher number of histidine residues would be able to bind to the columnmore tightly than those with fewer histidine residues.

Several different types of immobilized metal ion column have been developed toseparate various proteins (e.g. Fe, Co, Cd, Ni, or Zn). Protein separation in IMACgenerally depends on the strength of the metal ion-protein bond. Thus, choosing thetype of immobilized ion is crucial to the success protein separation. By far the mostwidely-used technique is to use an immobilized nickel column, and to engineer poly-histidine tags of six or more residues onto the recombinant proteins of interest. Onething to keep in mind is that the binding between metal ion and protein must bereversible, allowing elution of bounded protein at later steps. Three different elutionstrategies can be applied to IMAC competitive elution, stripping elution and pHAdjustment.

Page 46: Grundlagen und Anwendung moderner Trennverfahren · Mono-phosphorylated peptide (m/z . 2252.25) identified as RIADPEHDHTGFLTE. p. YVATRW (SwissProt as database) MS/MS analysis of

MACHEREY-NAGEL´s concept

Protino Ni-IDA/TEDProtino Ni-IDA/TED – purification of His-tag proteins

Protino Ni-TED

Protino Ni-IDA

TED (tris(carboxymethyl)ethylene diamine)

IDA (iminodiacetic acid)

Page 47: Grundlagen und Anwendung moderner Trennverfahren · Mono-phosphorylated peptide (m/z . 2252.25) identified as RIADPEHDHTGFLTE. p. YVATRW (SwissProt as database) MS/MS analysis of

MOACMetal Oxide Affinity Chromatography

O OP

O OR

TiO2 TiO2

Mechanism: Bridging Bidentate

for specific binding of phosphopeptides!

Example

Page 48: Grundlagen und Anwendung moderner Trennverfahren · Mono-phosphorylated peptide (m/z . 2252.25) identified as RIADPEHDHTGFLTE. p. YVATRW (SwissProt as database) MS/MS analysis of
Page 49: Grundlagen und Anwendung moderner Trennverfahren · Mono-phosphorylated peptide (m/z . 2252.25) identified as RIADPEHDHTGFLTE. p. YVATRW (SwissProt as database) MS/MS analysis of
Page 50: Grundlagen und Anwendung moderner Trennverfahren · Mono-phosphorylated peptide (m/z . 2252.25) identified as RIADPEHDHTGFLTE. p. YVATRW (SwissProt as database) MS/MS analysis of
Page 51: Grundlagen und Anwendung moderner Trennverfahren · Mono-phosphorylated peptide (m/z . 2252.25) identified as RIADPEHDHTGFLTE. p. YVATRW (SwissProt as database) MS/MS analysis of

DHB as “excluder“ or “displacer“

Page 52: Grundlagen und Anwendung moderner Trennverfahren · Mono-phosphorylated peptide (m/z . 2252.25) identified as RIADPEHDHTGFLTE. p. YVATRW (SwissProt as database) MS/MS analysis of

Karl Mechtler et. al

Page 53: Grundlagen und Anwendung moderner Trennverfahren · Mono-phosphorylated peptide (m/z . 2252.25) identified as RIADPEHDHTGFLTE. p. YVATRW (SwissProt as database) MS/MS analysis of

poly(divinylbenzene)

TiO2 < 100 nm

ZrO2 < 100 nm

Preparation of - Hollow MonolithTM

O OP

O OR

TiO2 TiO2Mechanism: Bridging Bidentate

Hollow MonolithTM

Example

Page 54: Grundlagen und Anwendung moderner Trennverfahren · Mono-phosphorylated peptide (m/z . 2252.25) identified as RIADPEHDHTGFLTE. p. YVATRW (SwissProt as database) MS/MS analysis of

Enrichment of Phosphopeptides

... embeddedTiO2/ZrO2

... Phosphorylated Peptides

Page 55: Grundlagen und Anwendung moderner Trennverfahren · Mono-phosphorylated peptide (m/z . 2252.25) identified as RIADPEHDHTGFLTE. p. YVATRW (SwissProt as database) MS/MS analysis of

Enrichment of in vitro phosphorylated ERK1 digest

MALDI MS spectra:

1.) before enrichment (A)

2.) after enrichment with poly(DVB)-TiO2/ZrO2 tips (B)

Signals at m/z 2252.25 and m/z 2332.23 correspond to phosphorylated peptides

Collaboration with Prof. Lukas Huber, Biocenter - Innsbruck

Page 56: Grundlagen und Anwendung moderner Trennverfahren · Mono-phosphorylated peptide (m/z . 2252.25) identified as RIADPEHDHTGFLTE. p. YVATRW (SwissProt as database) MS/MS analysis of

Mono-phosphorylated peptide (m/z 2252.25) identified as RIADPEHDHTGFLTEpYVATRW (SwissProt as database)

MS/MS analysis of enriched phosphopeptides from ERK1 digest

Identification of in vitro phosphorylated ERK1MS/MS Analysis

Page 57: Grundlagen und Anwendung moderner Trennverfahren · Mono-phosphorylated peptide (m/z . 2252.25) identified as RIADPEHDHTGFLTE. p. YVATRW (SwissProt as database) MS/MS analysis of

Activating: ACN/0.1% TFA twice

Equilibrating: 1) H2O/0.1% TFA two times. 2)50% ACN/0.1% TFA containing DHB (20 mg/mL)

Loading: 50% ACN/0.1% TFA containing DHB (20 mg/mL)

Washing: 50% ACN/0.1% TFA containing DHB (20 mg/mL) ,x5Additionally, two washing steps with 80% ACN/0.1% TFA and one washing step with deionized water were performed.

Eluting: 20% ACN/ 50 mM H3PO4, ca 1% NH4OH (pH 10.5)

matrix composition:10 mg/ml DHB80% ACN0.2% H3PO41 % TFA

0

1

2

3

4

5

4x10

Inte

ns. [

a.u.

]

2567.319

1709.807

1502.872

2963.477

2647.3481993.086

2077.040

0

1

2

3

4

5

4x10

Inte

ns. [

a.u.

]

Sample before enrichment

Sample after Ti/Zr-Tipenrichment.8 P-peptides detected

2586.314

ZipTip-MC tips,4 P-peptides detected

2647.1151

2

3

4

5

Inte

ns. [

a.u.

]

1400 1600 1800 2000 2200 2400 2600 2800

m/z

1501.669

1992.682

2587.218

x10 4

0

8 phosphopeptides in p57 protein could be detected after Ti/Zr-Tip enrichment, only 4 with ZipTip MC IMAC

Page 58: Grundlagen und Anwendung moderner Trennverfahren · Mono-phosphorylated peptide (m/z . 2252.25) identified as RIADPEHDHTGFLTE. p. YVATRW (SwissProt as database) MS/MS analysis of

1- 21 2567 GSYPYDVPDYASLEFTVLRPR phosphorylated1- 21 2646 GSYPYDVPDYASLEFTVLRPR 2xphosphorylated

Collaboration with Biocenter Innsbruck

P57 peptides detected after phosphopeptides enrichment#1_2183_ xxxxxx_HAp57wt +src _TiZr

Start - End Observed Mr(expt) Mr(calc) Delta Miss Sequence32 - 44 1485.7451 1484.7378 1484.7260 0.0119 0 R.SLFGPVDHEELSR.E 50 - 60 1272.6811 1271.6738 1271.6106 0.0633 0 R.LAELNAEDQNR.W 50 - 72 2883.3306 2882.3234 2882.2929 0.0304 1 R.LAELNAEDQNRWDYDFQQDMPLR.G Oxidation (M) 50 - 72 2963.3517 2962.3444 2962.2593 0.0852 1 R.LAELNAEDQNRWDYDFQQDMPLR.G Oxidation (M); Phospho (Y) 61 - 72 1709.6695 1708.6622 1708.6593 0.0029 0 R.WDYDFQQDMPLR.G Oxidation (M); Phospho (Y) 61 - 76 2076.8559 2075.8486 2075.8561 -0.0075 1 R.WDYDFQQDMPLRGPGR.L Oxidation (M); Phospho (Y) 77 - 92 1912.9939 1911.9867 1911.9003 0.0864 0 R.LQWTEVDSDSVPAFYR.E 77 - 92 1992.9086 1991.9013 1991.8666 0.0347 0 R.LQWTEVDSDSVPAFYR.E Phospho (Y) 266 - 278 1502.7793 1501.7721 1501.7582 0.0139 1 K.KLSGPLISDFFAK.R Phospho (ST) 287 - 312 2587.1004 2586.0931 2586.1422 -0.0490 0 K.SSGDVPAPCPSPSAAPGVGSVEQTPR.K Phospho (ST)

Page 59: Grundlagen und Anwendung moderner Trennverfahren · Mono-phosphorylated peptide (m/z . 2252.25) identified as RIADPEHDHTGFLTE. p. YVATRW (SwissProt as database) MS/MS analysis of

Automation of Sample Preparation

• Specific enrichment• Purification• Desalting

1. sample loading

laser

2. sample spotting

3. sample analysis 4. data processing

A collaboration with PhyNexus Inc., San Jose, CA, USA

Page 60: Grundlagen und Anwendung moderner Trennverfahren · Mono-phosphorylated peptide (m/z . 2252.25) identified as RIADPEHDHTGFLTE. p. YVATRW (SwissProt as database) MS/MS analysis of

α-caseinPhospho TiZrTiO2/ZrO2PhyNexus

ZipTipMC-Fe3+

Millipore

MonoTipTiO2

GL Sciences

TopTipTiO2

Glygen

TopTipZrO2

Glygen

total number ofphosphopeptides 20 7 11 11 9

ß-caseinPhospho TiZrTiO2/ZrO2PhyNexus

ZipTipMC-Fe3+

Millipore

MonoTipTiO2

GL Sciences

TopTipTiO2

Glygen

TopTipZrO2

Glygen

total number ofphosphopeptides 5 4 5 2 1

Comparative study with commercial products

Page 61: Grundlagen und Anwendung moderner Trennverfahren · Mono-phosphorylated peptide (m/z . 2252.25) identified as RIADPEHDHTGFLTE. p. YVATRW (SwissProt as database) MS/MS analysis of

+

+

[60]fullerenoacetylchloride[811,96]

[60]epoxy fullerene[736,64]

aminopropylSilica fullerene bonded Silica

aminopropylSilica

SiHO

SiOH2N Si

OH

OH

SiHO

SiHO

SiOH2N Si

OH

OH

SiHO

Synthesis of C60-Silica

Fullerene C60-amino silica

fullerene bonded Silica

Example

Page 62: Grundlagen und Anwendung moderner Trennverfahren · Mono-phosphorylated peptide (m/z . 2252.25) identified as RIADPEHDHTGFLTE. p. YVATRW (SwissProt as database) MS/MS analysis of

peptides with multiple phosphorylations – MS

monophosphorylated peptides

Single negatively charged group higher charge states in positive

ionization mode Single loss of phosphoric acid

peptides with multiplephosphorylated amino acids

multiple negatively charged moieties

low charge states preferred multiple losses of phosphoric acid

occur

PO

OHO

O

NO

NO

NO

NO

NO

NO

NO

NO

NO

NO

PO

OHO

OP

OOH

O

O

PO

OHO

O

PO

OHO

O

NO

NO

NO

NO

NO

NO

NO

NO

NO

NO

Page 63: Grundlagen und Anwendung moderner Trennverfahren · Mono-phosphorylated peptide (m/z . 2252.25) identified as RIADPEHDHTGFLTE. p. YVATRW (SwissProt as database) MS/MS analysis of

Enrichment and Separation of Mono- from Multi-phosphorylated Peptides Utilizing C60-fullerene silica

peptides bind to C60-fullerene silica

1

2

Elution of multi-phosphorylated peptides with 0.1 M NH4OH

3Elution of mono-phosphorylated peptides with 20% ACN and 1% TFA

4

Elution of non-phosphorylated

peptides with 80% ACN and 1 % TFA

Page 64: Grundlagen und Anwendung moderner Trennverfahren · Mono-phosphorylated peptide (m/z . 2252.25) identified as RIADPEHDHTGFLTE. p. YVATRW (SwissProt as database) MS/MS analysis of

Figure 1: Batch experiment, (A) fractionation of multi-phosphorylated peptide by elution with 0.1 M NH4OH and (B) fractionation of mono-phosphorylated peptide by elution 1% TFA in 20% ACN

Enrichment and Separation of Mono- from Multi-phosphorylated Peptides Utilizing C60-fullerene silica

Page 65: Grundlagen und Anwendung moderner Trennverfahren · Mono-phosphorylated peptide (m/z . 2252.25) identified as RIADPEHDHTGFLTE. p. YVATRW (SwissProt as database) MS/MS analysis of

Elution with 0.1 M NH4OH

Elution with 1% TFA in 20% ACN

Elution with 1% TFA in 80% ACN

Enrichment and Separation of Mono- from Multi-phosphorylated Peptides Utilizing C60-fullerene silica

α-casein tryptic digest

Page 66: Grundlagen und Anwendung moderner Trennverfahren · Mono-phosphorylated peptide (m/z . 2252.25) identified as RIADPEHDHTGFLTE. p. YVATRW (SwissProt as database) MS/MS analysis of

A new type of ion metal chelate affinity chromatography (IMAC) using trivalent lanthanide ions for phosphopeptide enrichment

Mirza, M.R.; Rainer, M. (); Messner, C.B. et al. A new type of metal chelate affinity chromatography using trivalent lanthanide ions for phosphopeptide enrichment. Analyst (2013) 138(10), 2995-3004.

(A) Scheme for the radical initiated polymerization of poly(VPA/DVB)

(B) Proposed interaction of trivalent erbium ions with the phosphonate-polymer

DVB Vinylphosphonic acid

IMAC loaded with Er3+

ErCl3

Page 67: Grundlagen und Anwendung moderner Trennverfahren · Mono-phosphorylated peptide (m/z . 2252.25) identified as RIADPEHDHTGFLTE. p. YVATRW (SwissProt as database) MS/MS analysis of

All mass signals which are labeled with asterisks (*) represent phosphopeptides

A new type of metal chelate affinity chromatography using trivalent lanthanide ions for phosphopeptide enrichment

(A) α-, β-casein and ovalbumin digest before enrichment, 6 PP

(B) phosphopeptide fraction after enrichment with La-IMAC, 18 PP

(C) phosphopeptide fraction after enrichment with Er-IMAC, 23 PP

(D) organic ACN wash after basic elution non-phosphorylated peptides (2 PP)

All measurements were recorded on an Ultraflex I (Bruker Daltonics) MALDI-TOF/TOF-MS in reflectronmode. Mass spectra were recorded by summing 500 laser shots. The laser power was adjusted between 30 and 50% of its maximal intensity, using a 337 nm nitrogen laser having a frequency of 50 Hz.

Page 68: Grundlagen und Anwendung moderner Trennverfahren · Mono-phosphorylated peptide (m/z . 2252.25) identified as RIADPEHDHTGFLTE. p. YVATRW (SwissProt as database) MS/MS analysis of

VYGKTSpHLR

KIGEGTpYGVVYK

HeLa cell lysate (1 mg/mL) spiked with two synthetic phosphopeptides (50 fmol/µl)

after specific enrichment using Er-IMAC

High Selectivity!

A new type of metal chelate affinity chromatography using trivalent lanthanide ions for phosphopeptide enrichment

Page 69: Grundlagen und Anwendung moderner Trennverfahren · Mono-phosphorylated peptide (m/z . 2252.25) identified as RIADPEHDHTGFLTE. p. YVATRW (SwissProt as database) MS/MS analysis of

Binding energies (kcal/mol):

… ethylphosphates show high binding energies towards the lanthanide complexes!

Ligand La(III)-IMAC Ho(III)-IMAC Er(III)-IMAC

(H2O)2 -60.3 -72.9 -112.3

(CH3CH2PO4H)- -168.4 -174.0 -269.1

[(OH)-]2 -327.9 -341.0 -426.0

CH3-COOH -43.8 -53.5 -109.3

A new type of ion metal chelate affinity chromatography (IMAC) using trivalent lanthanide ions for phosphopeptide enrichment

Results: Ion can coordinate tetradentate to the polymer. Free coordination sites for capturing phosphopeptides. Binding energy: -939 kcal/mol (Er(III))

Geometry optimisations using HF and MP2 methods

Page 70: Grundlagen und Anwendung moderner Trennverfahren · Mono-phosphorylated peptide (m/z . 2252.25) identified as RIADPEHDHTGFLTE. p. YVATRW (SwissProt as database) MS/MS analysis of

Christoph Messner

Mulliken partial charges:

Ligand La(III)-IMAC

Ho(III)-IMAC Er(III)-IMAC

(H2O)2 1.83 2.13 2.59

(CH3CH2PO4H)- 1.67 2.04 2.54

[(OH)-]2 1.62 2.03 2.57

CH3-COOH 1.78 2.11 2.60

Er(III) complex is strongly polarised → strong electrostatic interactions

A new type of ion metal chelate affinity chromatography (IMAC) using trivalent lanthanide ions for phosphopeptide enrichment

Geometry optimisations using HF and MP2 methods

Why shows Er(III) as an immobilised ion the best performance?

Mirza, M.R.; Rainer, M. (); Messner, C.B. et al. A new type of metal chelate affinity chromatography using trivalent lanthanide ions for phosphopeptide enrichment. Analyst (2013) 138(10), 2995-3004.

Page 71: Grundlagen und Anwendung moderner Trennverfahren · Mono-phosphorylated peptide (m/z . 2252.25) identified as RIADPEHDHTGFLTE. p. YVATRW (SwissProt as database) MS/MS analysis of

Güzel, Yüksel, et al. "Development of erbium phosphate doped poly (glycidyl methacrylate/ethylenedimethacrylate) spin columns for selective enrichment of phosphopeptides." Journal of separation

science 38.8 (2015): 1334-1343.

Development of erbium phosphate doped poly(glycidyl methacrylate/ethylenedimethacrylate) spin columns for selective enrichment of phosphopeptides

SEM Picture

Page 72: Grundlagen und Anwendung moderner Trennverfahren · Mono-phosphorylated peptide (m/z . 2252.25) identified as RIADPEHDHTGFLTE. p. YVATRW (SwissProt as database) MS/MS analysis of

milk Human saliva

30 Phosphopeptides 14 Phosphopeptides

A

B

before enrichment

Development of erbium phosphate doped poly(glycidyl methacrylate/ethylenedimethacrylate) spin columns for selective enrichment of phosphopeptides

before enrichment

after enrichment after enrichment

Page 73: Grundlagen und Anwendung moderner Trennverfahren · Mono-phosphorylated peptide (m/z . 2252.25) identified as RIADPEHDHTGFLTE. p. YVATRW (SwissProt as database) MS/MS analysis of

Sensitivity Study

Ratio: synthetic phosphopeptideversus HeLa cell lysate 1:2000

Development of erbium phosphate doped poly(glycidyl methacrylate/ethylenedimethacrylate) spin columns for selective enrichment of phosphopeptides

A... before enrichmentB... after enrichment

5 fmol/µl

Page 74: Grundlagen und Anwendung moderner Trennverfahren · Mono-phosphorylated peptide (m/z . 2252.25) identified as RIADPEHDHTGFLTE. p. YVATRW (SwissProt as database) MS/MS analysis of

74

Protein Verdau

DTT Dithiothreitol

Page 75: Grundlagen und Anwendung moderner Trennverfahren · Mono-phosphorylated peptide (m/z . 2252.25) identified as RIADPEHDHTGFLTE. p. YVATRW (SwissProt as database) MS/MS analysis of

75

Protein Verdau

(DTT Dithiothreitol)

(CHAPS 3-[(3-Cholamidopropyl)dimethylammonio]-1-propanesulfonate hydrate)

Page 76: Grundlagen und Anwendung moderner Trennverfahren · Mono-phosphorylated peptide (m/z . 2252.25) identified as RIADPEHDHTGFLTE. p. YVATRW (SwissProt as database) MS/MS analysis of

Trypsin Mostly, proteomics scientists use trypsin to

generate peptides− Trypsin cleaves after the positively charged amino

acids arginine [R] and lysine [K], generating multiply positively charged peptides

− Most tryptic peptides have an ideal size for mass spectrometry (500-4000 Da)

− Tryptic peptides fragment very well in the mass spectrometer, generating good quality sequence information

76

Protein Verdau

Page 77: Grundlagen und Anwendung moderner Trennverfahren · Mono-phosphorylated peptide (m/z . 2252.25) identified as RIADPEHDHTGFLTE. p. YVATRW (SwissProt as database) MS/MS analysis of

Peptide Mass Fingerprint

++

++

+++

trypsin

Inte

nsity

m/z

++

++

+++

77

Page 78: Grundlagen und Anwendung moderner Trennverfahren · Mono-phosphorylated peptide (m/z . 2252.25) identified as RIADPEHDHTGFLTE. p. YVATRW (SwissProt as database) MS/MS analysis of

Monolithic Extraction Tips for Enzymatic Digestion

Trypsin in TrisHCl-buffer =

2h , 5°C

GMADVBAIBNToluolDecanol

=+

2h , 95°C

+

Page 79: Grundlagen und Anwendung moderner Trennverfahren · Mono-phosphorylated peptide (m/z . 2252.25) identified as RIADPEHDHTGFLTE. p. YVATRW (SwissProt as database) MS/MS analysis of

BSAα-caseine

+ DTT

Enzyme-Tip

=> =>

+ iodoacetamide

15mins, RT, in dark

15 mins, 60°C

15 mins, 20°C, in

dark

=>

30 mins (in-tip) 60 mins (literature)

DenaturationProtein

Monolithic Extraction Tips for Enzymatic Digestion

Page 80: Grundlagen und Anwendung moderner Trennverfahren · Mono-phosphorylated peptide (m/z . 2252.25) identified as RIADPEHDHTGFLTE. p. YVATRW (SwissProt as database) MS/MS analysis of

Microwave-Assisted In-Tip Digestion

Total Time 45 min!conventional digestion time: 6-10 h

Page 81: Grundlagen und Anwendung moderner Trennverfahren · Mono-phosphorylated peptide (m/z . 2252.25) identified as RIADPEHDHTGFLTE. p. YVATRW (SwissProt as database) MS/MS analysis of

Results - Comparison Study

α-casein digested, eluted from enzyme-Tips with Tip-Technology

Glygen Corp.

Tip

GL SciencesGlygen Corp.

Glygen Corp.

Company

0

10

20

30

40

50

60

70

80

90

a-casein myoglobin BSA

NT1CARTRY

NT1TRY

NT1C18TRY

MonoTip™

GMA/DVB-Tips

sequ

ence

cove

rage

[%]